Alterity Therapeutics Highlights New Publications On ATH434 In Parkinson's Disease
January 28, 2022 at 11:02 AM EST
Alterity Therapeutics's(NASDAQ: ATHE) data in an animal model of Multiple System Atrophy (MSA) were published in the Journal ...